Relatively High Pulmonary and Cardiovascular Mortality Rates in Screening-detected Aneurysmal Patients Without Previous Hospital Admissions

European Journal of Vascular and Endovascular Surgery

Volumn 33, Issue 1, 2007, Pages 94-99

  Lindholt, J S ^a  

^a VIBORG HOSPITAL   (Denmark)

Author keywords

Abdominal aortic aneurysm; Aspirin; Atherosclerosis; Mass screening; Prevention; Statins

Indexed keywords

ABDOMINAL AORTA ANEURYSM; ACUTE HEART INFARCTION; ADULT; AGE; AGED; ARTICLE; CALCULATION; CARDIOVASCULAR DISEASE; CAUSE OF DEATH; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL OBSERVATION; CLINICAL TRIAL; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HUMAN; HYPERTENSION; INFORMATION PROCESSING; ISCHEMIC HEART DISEASE; LIFE TABLE; LUNG DISEASE; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MORTALITY; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; RANDOMIZED CONTROLLED TRIAL; REGRESSION ANALYSIS; RISK ASSESSMENT; STATISTICAL SIGNIFICANCE; STROKE; TRANSIENT ISCHEMIC ATTACK;

AGED; AORTIC ANEURYSM, ABDOMINAL; CARDIOVASCULAR DISEASES; DENMARK; FOLLOW-UP STUDIES; HOSPITALIZATION; HUMANS; HYPERTENSION; ISCHEMIC ATTACK, TRANSIENT; LIFE TABLES; MALE; MASS SCREENING; MIDDLE AGED; MYOCARDIAL INFARCTION; MYOCARDIAL ISCHEMIA; PERIPHERAL VASCULAR DISEASES; PROPORTIONAL HAZARDS MODELS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATORY TRACT DISEASES; RISK ASSESSMENT; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33845221682     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2006.06.007     Document Type: Article

References (20)

1. Lindholt JS. Considerations and experiences of screening for abdominal aortic aneurysms (PhD thesis), FADĹs forlag, Copenhagen 1998.
2. Ashton H.A., Buxton M.J., Day N.E., Kim L.G., Marteau T.M., Scott R.A., et al., Multicentre Aneurysm Screening Study Group. The Multicentre Aneurysm Screening Study (MASS) into the effect of abdominal aortic aneurysm screening on mortality in men: a randomised controlled trial. Lancet 360 (2002) 1531-1539
3. Multicentre Aneurysm Screening Study Group. Multicentre aneurysm screening study (MASS): cost effectiveness analysis of screening for abdominal aortic aneurysms based on four year results from randomised controlled trial. BMJ 325 (2002) 1135-1138
4. Lindholt J.S., Juul S., Fasting H., and Henneberg E.W. Screening for abdominal aortic aneurysms: single centre randomised controlled trial. BMJ 330 (2005) 750-752
5. Lindholt J.S., Juul S., Fasting H., and Henneberg E.W. Cost-effectiveness analysis of screening for abdominal aortic aneurysms based on five year results from a randomised hospital based mass screening trial. Eur J Vasc Endovasc Surg 32 (2006) 9-15
6. W.H.O. Classification of diseases. 2nd ed. (1986), Sundhedsstyrelsen, Copenhagen
7. Lindholt J.S., Jorgensen B., Klitgaard N.A., and Henneberg E.W. Systemic levels of cotinine and elastase, but not pulmonary function, are associated with the progression of small abdominal aortic aneurysms. Eur J Vasc Endovasc Surg 26 (2003) 418-422
8. Lindholt J.S., Henneberg E.W., Fasting H., and Juul S. Hospital based screening of 65-73 year old men for abdominal aortic aneurysms in the county of Viborg, Denmark. J Med Screen 3 (1996) 43-46
9. Busch T., Sirbu H., Aleksic I., Friedrich M., and Dalichau H. Development of cardiovascular procedures before abdominal aortic aneurysm repair over 16 years. Ann Thorac Cardiovasc Surg 5 (1999) 326-330
10. Nielsen H.W., and Tushsen M.V. [Validity of the diagnosis "essential hypertension" in the national patient registry]. Ugeskr Laeger 158 (1996) 163-167
11. Madsen M., Balling H., and Eriksen I.S. [The validity of the diagnosis of acute mycardial infarction in two registries: the Heart Registry and the National Patient Registry]. Ugeskr Laeger 152 (1990) 808-814
12. Sorensen HT. [Chronical obstructive pulmonary disease in the counties of North Jutland, Viborg and Aarhus]. Department of Clinical Epidemiology, Universityhospital of Aarhus 2005, rapport no. 15.
13. Critchley J., and Capewell S. Smoking cessation for the secondary prevention of coronary heart disease. Cochrane Database Syst Rev 1 (2004) CD003041
14. Turner D., Wailoo A., Nicholson K., Cooper N., Sutton A., and Abrams K. Systematic review and economic decision modelling for the prevention and treatment of influenza A and B. Health Technol Assess 7 35 (2003) iii-iv, xi-xiii, 1-170
15. Bredie S.J., Wollersheim H., Verheugt F.W., and Thien T. Low-dose aspirin for primary prevention of cardiovascular disease. Semin Vasc Med 3 (2003) 177-184
16. Cheung B.M., Lauder I.J., Lau C.P., and Kumana C.R. Meta-analysis of large randomized controlled trials to evaluate the impact of statins on cardiovascular outcomes. Br J Clin Pharmacol 57 (2004) 640-651
17. Turnbull F., and Blood Pressure Lowering Treatment Trialists' Collaboration. Effects of different blood-pressure-lowering regimens on major cardiovascular events: results of prospectively-designed overviews of randomised trials. Lancet 362 (2003) 1527-1535
18. Steinmetz E.F., Buckley C., Shames M.L., Ennis T.L., Vanvickle-Chavez S.J., Mao D., et al. Treatment with simvastatin suppresses the development of experimental abdominal aortic aneurysms in normal and hypercholesterolemic mice. Ann Surg 241 (2005) 92-101
19. Petersen E., Wagberg F., and Angquist K.A. Does lipoprotein(a) inhibit elastolysis in abdominal aortic aneurysms?. Eur J Vasc Endovasc Surg 26 (2003) 423-428
20. Heart Protection Study Collaborative Group. MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial. Lancet 360 (2002) 7-22